Dupilumab-associated ocular surface disease is characterized by a shift from Th2/Th17 toward Th1/Th17 inflammation.
Thormann K, Lüthi AS, Deniau F, Heider A, Cazzaniga S, Radonjic-Hoesli S, Lehmann M, Schlapbach C, Herzog EL, Kreuzer M, Zinkernagel MS, Akdis CA, Zysset-Burri DC, Simon HU, Simon D.
Thormann K, et al. Among authors: zysset burri dc.
Allergy. 2024 Apr;79(4):937-948. doi: 10.1111/all.16045. Epub 2024 Feb 5.
Allergy. 2024.
PMID: 38317432
Free article.